What is Si02?
SiO2 Material Science operates as a primary packaging company, distinguished by its proprietary vyterialTM coating technology. This innovation merges the advantages of glass and polymers, offering a superior alternative for pharmaceutical and biotech packaging. The company's product portfolio includes syringes, vials, and blood collection tubes, all designed to meet stringent industry standards. With a robust intellectual property portfolio of over 300 patents and advanced manufacturing capabilities in Auburn, Alabama, SiO2 is positioned as a leader in sustainable and effective drug delivery solutions.
How much funding has Si02 raised?
Si02 has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Si02
PPP
Public-Private Partnership
What's next for Si02?
The recent major strategic investment signals a pivotal moment for Si02, likely enabling the company to accelerate its research and development initiatives, expand manufacturing capacity, and broaden its market reach. This capital infusion is expected to fuel further innovation in their unique coating technology and support the scaling of production to meet the growing global demand for high-quality pharmaceutical packaging. The company's focus on patents and advanced materials suggests a continued emphasis on technological leadership and market differentiation.
See full Si02 company page
